Zinc-mediated binding of a low-molecular-weight stabilizer of the host anti-viral factor apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G

被引:21
作者
Radwan, Mohamed O. [1 ]
Sonoda, Sachiko [1 ]
Ejima, Tomohiko [1 ]
Tanaka, Ayumi [1 ]
Koga, Ryoko [1 ]
Okamoto, Yoshinari [1 ]
Fujita, Mikako [2 ]
Otsuka, Masami [1 ]
机构
[1] Kumamoto Univ, Dept Bioorgan Med Chem, Fac Life Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan
[2] Kumamoto Univ, Res Inst Drug Discovery, Sch Pharm, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan
关键词
APOBEC3G; Host anti-viral factor; HIV; Zinc; Biotin-avidin technology; Molecular docking; HIV-1 REVERSE TRANSCRIPTION; RESTRICTION FACTORS; CYTIDINE DEAMINASES; HUMAN APOBEC3G; VIF PROTEIN; DOMAIN; DESIGN; DNA; HYPERMUTATION; DERIVATIVES;
D O I
10.1016/j.bmc.2016.07.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G, A3G), is a human anti-virus restriction protein which works deaminase-dependently and - independently. A3G is known to be ubiquitinated by HIV-1 viral infectivity factor (Vif) protein, leading to proteasomal degradation. A3G contains two zinc ions at the N-terminal domain and the C-terminal domain. Four lysine residues, K-297, K-301, K-303, and K-334, are known to be required for Vif-mediated A3G ubiquitination and degradation. Previously, we reported compound SN-1, a zinc chelator that increases steady-state expression level of A3G in the presence of Vif. In this study, we prepared Biotin-SN-1, a biotinylated derivative of SN-1, to study the SN-1-A3G interaction. A pull-down assay revealed that Biotin-SN-1 bound A3G. A zinc-abstraction experiment indicated that SN-1 binds to the zinc site of A3G. We carried out a SN-1-A3G docking study using molecular operating environment. The calculations revealed that SN-1 binds to the C-terminal domain through Zn2+, H-216, P-247, C-288, and Y-315. Notably, SN-1-binding covers the H-257, E-259, C-288, and C-291 residues that participate in zinc-mediated deamination, and the ubiquitination regions of A3G. The binding of SN-1 presumably perturbs the secondary structure between C-288 and Y-315, leading to less efficient ubiquitination. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4398 / 4405
页数:8
相关论文
共 46 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   Design and synthesis of biotinylated inositol phosphates relevant to the biotin-avidin techniques [J].
Anraku, Kensaku ;
Inoue, Teruhiko ;
Sugimoto, Kenji ;
Morii, Takashi ;
Mori, Yasuo ;
Okamoto, Yoshinari ;
Otsuka, Masami .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2008, 6 (10) :1822-1830
[3]   Design and synthesis of biotinylated inositol 1,3,4,5-tetrakisphosphate targeting Grp1 pleckstrin homology domain [J].
Anraku, Kensaku ;
Inoue, Teruhiko ;
Sugimoto, Kenji ;
Kudo, Kota ;
Okamoto, Yoshinari ;
Morii, Takashi ;
Mori, Yasuo ;
Otsuka, Masami .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (22) :6833-6841
[4]   Highly Sensitive Analysis of the Interaction between HIV-1 Gag and Phosphoinositide Derivatives Based on Surface Plasmon Resonance [J].
Anraku, Kensaku ;
Fukuda, Ryota ;
Takamune, Nobutoki ;
Misumi, Shogo ;
Okamoto, Yoshinari ;
Otsuka, Masami ;
Fujita, Mikako .
BIOCHEMISTRY, 2010, 49 (25) :5109-5116
[5]   Promiscuous RNA Binding Ensures Effective Encapsidation of APOBEC3 Proteins by HIV-1 [J].
Apolonia, Luis ;
Schulz, Reiner ;
Curk, Tomaz ;
Rocha, Paula ;
Swanson, Chad M. ;
Schaller, Torsten ;
Ule, Jernej ;
Malim, Michael H. .
PLOS PATHOGENS, 2015, 11 (01) :1-22
[6]   APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts [J].
Bishop, Kate N. ;
Verma, Mohit ;
Kim, Eun-Young ;
Wolinsky, Steven M. ;
Malim, Michael H. .
PLOS PATHOGENS, 2008, 4 (12)
[7]   Design of angiotensin converting enzyme inhibitors [J].
Cushman, DW ;
Ondetti, MA .
NATURE MEDICINE, 1999, 5 (10) :1110-1112
[8]   Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All [J].
Desimmie, Belete A. ;
Delviks-Frankenberrry, Krista A. ;
Burdick, Ryan C. ;
Qi, DongFei ;
Izumi, Taisuke ;
Pathak, Vinay K. .
JOURNAL OF MOLECULAR BIOLOGY, 2014, 426 (06) :1220-1245
[9]   Evolutionary conflicts between viruses and restriction factors shape immunity [J].
Duggal, Nisha K. ;
Emerman, Michael .
NATURE REVIEWS IMMUNOLOGY, 2012, 12 (10) :687-695
[10]   An anti-HIV-1 compound that increases steady-state expression of apoplipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G [J].
Ejima, Tomohiko ;
Hirota, Mayuko ;
Mizukami, Tamio ;
Otsuka, Masami ;
Fujita, Mikako .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (04) :613-616